FLAVOXATE

SynDRA canonical compound SYN0007918 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	CHRM1 \| CHRM2
Mechanism of action	acetylcholine receptor antagonist
Indication	interstitial cystitis (IC) \| prostatitis \| urethritis \| urinary incontinence
Disease area	urology

All known targets

urispas
flavoxate hydrochloride
flavoxate HCl
Flavoxato
Bladuril
Flavossato
Flavoxatum
Urispas
Flavossato [DCIT]
Flavoxate HCI
Flavoxate HCL
Spasuret hydrochloride
AK 123
Bladderon (TN)
Bladuril (TN)
DW-61
Flavoxate (INN)
Flavoxate [INN:BAN]
Flavoxato [INN-Spanish]
Flavoxatum [INN-Latin]
Urispas (TN)
Uritac (TN)
Zopyran-8-carboxylate
Beta-piperidinoethyl 3-methylflavone-8-carboxylate
Piperidinoethyl-3-methylflavone-8-carboxylate
1-Piperidinoethanol, 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate
2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate
2-(piperidin-1-yl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate
2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylat
2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate
2-Piperidinoethyl-3-methyl-4-oxo-2-phenyl-4H-1-ben
2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate
2-piperidin-1-ylethyl 3-methyl-4-oxo-2-phenylchromene-8-carboxylate
2-piperidinoethyl 3-methylflavone-8-carboxylate
4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester
3E74Y80MEY
beta-piperidinoethyl 3-methylflavone-8-carboxylate
CHEBI:5088